Fig 4.

(A) DCF staining for ROS increased with A23187 treatment and was attenuated with exposure to 1 and 5 nM PTX3 (P1 and P5, respectively). (B) ROS activity as measured by fluorimetry increased(F.I. of DCF) in cells treated with 0 nM/mL and 5 nM/mL PTX3 (A0.3, A0.3+P1 and A0.3+P5, respectively), which was attenuated by treatment with PTX3. *p < 0.05 versus A23187 (0.3μg/mL) subjected to administrate PTX3. The statistical signification was marked as * for p < 0.05 compared with the control. 'CON' is abbreviated 'control' which is treated nothing.